From amphetamines to slimming pills, there is a long history of weight-loss drug crazes that ended in disappointment, or worse. Until anti-obesity medicines such as Wegovy and Zepbound, none of them had started out promisingly and then produced better and broader results.It is surprising, but studies of the health impact of the new generation of weight drugs have steadily brought more encouraging news. One published this week found that patients who took Novo Nordisk’s Wegovy sustained weight loss for up to four years. It builds on data from last November showing the drug reduced the risks of heart attacks and death.
從安非他明(Amphetamine)到瘦身藥丸，人類對減肥藥的狂熱有著悠久的歷史，但每一次都以失望告終，甚至是更糟。在Wegovy和Zepbound這類抗肥胖藥物出現之前，沒有任何一種藥物像它們這樣，在開始時令人充滿希望，隨後居然產生了更好、更廣泛的效果。